Legal & General Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-681
| Closed | -$6.14K | – | 3470 |
|
|
2024
Q1 | $6.14K | Hold |
681
| – | – | ﹤0.01% | 3276 |
|
|
2023
Q4 | $6.46K | Hold |
681
| – | – | ﹤0.01% | 3298 |
|
|
2023
Q3 | $8.11K | Hold |
681
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q2 | $16.7K | Sell |
681
-4
| -0.6% | -$98 | ﹤0.01% | 3183 |
|
|
2023
Q1 | $21.4K | Sell |
685
-1,098
| -62% | -$34.3K | ﹤0.01% | 3050 |
|
|
2022
Q4 | $126K | Buy |
1,783
+100
| +6% | +$7.04K | ﹤0.01% | 2764 |
|
|
2022
Q3 | $145K | Buy |
1,683
+190
| +13% | +$16.4K | ﹤0.01% | 2721 |
|
|
2022
Q2 | $123K | Buy |
1,493
+1,186
| +386% | +$97.7K | ﹤0.01% | 2794 |
|
|
2022
Q1 | $51K | Buy |
307
+28
| +10% | +$4.65K | ﹤0.01% | 2997 |
|
|
2021
Q4 | $47K | Hold |
279
| – | – | ﹤0.01% | 3042 |
|
|
2021
Q3 | $24K | Hold |
279
| – | – | ﹤0.01% | 3216 |
|
|
2021
Q2 | $15K | Hold |
279
| – | – | ﹤0.01% | 3378 |
|
|
2021
Q1 | $17K | Hold |
279
| – | – | ﹤0.01% | 3187 |
|
|
2020
Q4 | $15K | Hold |
279
| – | – | ﹤0.01% | 3200 |
|
|
2020
Q3 | $13K | Sell |
279
-35
| -11% | -$1.63K | ﹤0.01% | 3126 |
|
|
2020
Q2 | $16K | Sell |
314
-63
| -17% | -$3.21K | ﹤0.01% | 3155 |
|
|
2020
Q1 | $16K | Buy |
377
+163
| +76% | +$6.92K | ﹤0.01% | 2994 |
|
|
2019
Q4 | $9K | Hold |
214
| – | – | ﹤0.01% | 3305 |
|
|
2019
Q3 | $7K | Hold |
214
| – | – | ﹤0.01% | 3303 |
|
|
2019
Q2 | $15K | Hold |
214
| – | – | ﹤0.01% | 3279 |
|
|
2019
Q1 | $38K | Buy |
214
+136
| +174% | +$24.2K | ﹤0.01% | 2817 |
|
|
2018
Q4 | $18K | Hold |
78
| – | – | ﹤0.01% | 3117 |
|
|
2018
Q3 | $17K | Buy |
+78
| New | +$17K | ﹤0.01% | 3248 |
|